|Table of Contents|

Diallyl disulfide inhibits invasion and epithelial-mesenchymal transition in human gastric cancer cells through LIMK1-Cofilin1 pathway

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 21
Page:
3908-3913
Research Field:
Publishing date:

Info

Title:
Diallyl disulfide inhibits invasion and epithelial-mesenchymal transition in human gastric cancer cells through LIMK1-Cofilin1 pathway
Author(s):
MA Yanhua12XIA Hong1LIU Fang1SU Jian13XIANG Shulin1SU Qi13
1.Cancer Research Institute,University of South China,Hunan Hengyang 421001,China;2.Department of Oncology,Sanya Central Hospital,Hainan Sanya 572009,China;3.Hunan Clinical Research Center for Gastric Cancer Prevention and Treatment,Department of Pathology,the Second Affiliated Hospital,University of South China,Hunan Hengyang 421001,China.
Keywords:
diallyl disulfidehuman gastric cancer MGC803 cellsLIMK1-Cofilin1 pathwayproliferationmigrationinvasionepithelial-mesenchymal transition
PACS:
R735.2
DOI:
10.3969/j.issn.1672-4992.2023.21.002
Abstract:
Objective:To investigate the effects of diallyl disulfide(DADS) on invasion and epithelial-mesenchymal transformation(EMT) of human gastric cancer MGC803 cells and its mechanism.Methods:In vitro and in vivo experiments were divided into MGC803 cell group and DADS treatment group.MTT,scratch test and invasion test were used to determine the effects of DADS on proliferation,migration and invasion.The expression of EMT-related proteins in LIMK1-Cofilin1 pathway was detected by Western Blot.The morphological changes of MGC803 cells were observed by phase contrast microscopy.The effects of DADS on tumor transplantation were tested in nude mice.Results:MTT showed that DADS could inhibit MGC803 cell proliferation in a time-dependent manner(P<0.05).Scratch test showed that the cell migration distance of DADS group was (59.9±1.9)μm shorter than that of MGC803 group (127.1±2.0)μm(P<0.01).Invasion test showed that DADS group had (30.0±2.6) transmembrane cells significantly decreased compared with MGC803 group (48.3±2.5)(P<0.01).Western Blot showed that after DADS treatment for 6 h,12 h,24 h and 48 h,LIMK1,p-LIMK1 and p-Cofilin1(P<0.001),Vimentin(P<0.001) and MMP-9(P<0.001) were down-regulated in a time-dependent manner,while E-cadherin (P=0.001) and TIMP-3 were significantly up-regulated (P<0.001) in MGC803 cells respectively.Contrast microscopy showed that after DADS treatment,the fibroblast-like cells decreased and the atypia decreased significantly.In nude mice,the tumor growth of DADS group was slower than MGC803 cell group(P<0.05),the tumor weight of DADS group was lower than MGC803 cell group,the tumor inhibition rate was 60.19%(P<0.001),and the positive expression of Ki-67,Vimentin,Snail and CD34 decreased,and the expression of E-cadherin was increased.Conclusion:DADS can inhibit MGC803 cell invasion and EMT through LIMK1-Cofilin1 pathway in vitro and in vivo.

References:

[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[2] YANG L,YING X,LIU S,et al.Gastric cancer:Epidemiology,risk factors and prevention strategies [J].Chin J Cancer Res,2020,32(6):695-704.
[3] HUANG Z,ZHANG Z,ZHOU C,et al.Epithelial-mesenchymal transition:The history,regulatory mechanism,and cancer therapeutic opportunities [J].Med Comm,2022,3(2):e144.
[4] VILLALONGA E,MOSRIN C,NORMAND T,et al.LIM kinases,LIMK1 and LIMK2,are crucial node actors of the cell fate:molecular to pathological features [J].Cells,2023,12(5):805.
[5] RIBBA AS,FRABOULET S,SADOUL K,et al.The role of LIM kinases during development:a lens to get a glimpse of their implication in pathologies [J].Cells,2022,11(3):403.
[6] MITRA S,DAS R,EMRAN TB,et al.Diallyl disulfide:a bioactive garlic compound with anticancer potential[J].Front Pharmacol,2022,13:943967.
[7] SONG X,YUE Z,NIE L,et al.Biological functions of Diallyl disulfide,a garlic-derived natural organic sulfur compound [J].Evid Based Complement Alternat Med,2021,2021:5103626.
[8] SU B,SU J,HE H,et al.Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches [J].Oncol Rep,2015,33(5):2484-2494.
[9] 何慧,马艳华,苏波,等.二烯丙基二硫对人胃癌MGC803细胞Rac1-Pak1/Rock1通路的影响[J].中国药理学通报,2014,30(3):349-354. HE H,MA YH,SU B,et al.Effects of Diallyl disulfide on Rac1-Pak1/Rock1 pathway in human gastric cancer MGC803 cells[J].Chin Pharmacol Bul,2014,30(3):349-354.
[10] MA N,XU E,LUO Q,et al.Rac1:A regulator of cell migration and a potential target for cancer therapy[J].Molecules,2023,28(7):2976.
[11] BUDI HS,YOUNUS LA,LAFTA MH,et al.The role of miR-128 in cancer development,prevention,drug resistance,and immunotherapy [J].Front Oncol,2023,12:1067974.
[12] ZHANG S,SHI W,HU W,et al.DEP Domain-Containing Protein 1B(DEPDC1B) promotes migration and invasion in pancreatic cancer through the Rac1/PAK1-LIMK1-Cofilin1 signaling pathway[J].Onco Targets Ther,2020,13:1481-1496.
[13] WUFUER R,MA HX,LUO MY,et al.Downregulation of Rac1/PAK1/LIMK1/Cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy[J].Photodiagnosis Photodyn Ther,2021,33:102143.
[14] ZENG Y,REN M,LI YK,et al.Knockdown of RhoGDI2 represses human gastric cancer cell proliferation,invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway[J].Cancer Lett,2020,492:136-146.
[15] GUO D,LI YR,CHEN DF,et al.Regulatory effects of LIM kinase 1 on the proliferation and metastasis of hepatocellular carcinoma cells[J].Chinese Journal of Liver,2021,29(5):427-432.
[16] SUN X,LI S,LIN H.LIMK1 interacts with STK25 to regulate EMT and promote the proliferation and metastasis of colorectal cancer [J].J Oncol,2022,2022:3963883.
[17] LI ZF,YAO YD,ZHAO YY,et al.Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation,invasion,and migration of human osteosarcoma cells[J].J Clin Lab Anal,2020,34(9):e23362.
[18] 史玲,苏坚,孙晓勤,等.沉默LIMK1抑制人结肠癌SW480细胞上皮-间质转化[J].现代肿瘤医学,2020,28(13):2183-2188. SHI L,SU J,SUN XQ,et al.Silencing LIMK1 inhibits epithelial-mesenchymal transformation of human colon cancer SW480 cells [J].Modern Oncology,2020,28(13):2183-2188.
[19] ASHRAFIZADEH M,ZARRABI A,SABERIFAR S,et al.Nobiletin in cancer therapy:how this plant derived-natural compound targets various oncogene and onco-suppressor pathways [J].Biomedicines,2020,8(5):110.
[20] COLLINS R,LEE H,JONES DH,et al.Comparative analysis of small-molecule LIMK1/2 inhibitors:chemical synthesis,biochemistry,and cellular activity [J].J Med Chem,2022,65(20):13705-13713.
[21] 刘鑫慧,杨清.LIMK的研究进展[J].现代肿瘤医学,2018,26(01):137-141. LIU XH,YANG Q.Research progress of LIMK[J].Modern Oncology,2018,26(01):137-141.
[22] HANKE T,MATHEA S,WOORTMAN J,et al.Development and characterization of type I,type II,and type iII LIM-kinase chemical probes [J].J Med Chem,2022,65(19):13264-13287.
[23] KANG X,LI W,LIU W,et al.LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target [J].Oncogene,2021,40(19):3422-3433.
[24] ZHANG M,WANG R,TIAN J,et al.Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo [J].J Cell Mol Med,2021,25(12):5560-5571.
[25] XU S,HUANG H,TANG D,et al.Diallyl disulfide attenuates ionizing radiation-induced migration and invasion by suppressing Nrf2 signaling in non-small-cell lung cancer [J].Dose Response,2021,19(3):15593258211033114.
[26] SU J,HE H,LI Y,et al.Diallyl disulfide inhibits cell proliferation,epithelial-mesenchymal transition,and invasion through RORα-mediated downregulation of Wnt/β-catenin pathway in gastric cancer cells [J].J Food Drug Anal,2022,30(3):479-492.
[27] SU J,ZHOU Y,PAN Z,et al.Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer [J].Sci Rep,2017,7:45624.
[28] SU B,SU J,ZENG Y,et al.Diallyl disulfide inhibits TGF β1 induced upregulation of Rac1 and β catenin in epithelial mesenchymal transition and tumor growth of gastric cancer [J].Oncol Rep,2018,39(6):2797-2806.

Memo

Memo:
National Natural Science Foundation of China(No.81973532,81374013,81102854);国家自然科学基金(编号:81973532,81374013,81102854)
Last Update: 2023-09-28